Theme

Field-oriented
Sessions

Session Title

Pathology andMolecularClassification

Presentation
No.

Abstract
No.

Lecture title

SpeakerCountry

PAT-IS-01

SPKR-44

Histopathology and molecular pathology in the diagnosis of pediatric CNS tumors WHO Classification, Edition 5

David Ellison

USA

PAT-O-02

PATH-01

Molecular profiling of paediatric central nervous system tumours in Australasia – An
update on the AIM BRAIN and MNP2.0 projects

Elizabeth Algar

Australia

PAT-O-03

PATH-11

Prospective (epi-)genetic classification of > 1,000 pediatric CNS tumors—the MNP 2.0study

Dominik Sturm

Germany

PAT-P-04

PATH-04

An enhanced AI-driven platform for precision molecular brain tumor diagnostics

Martin SillGermany

PAT-P-05

PATH-06

Image-based machine learning classifier for pediatric posterior fossa tumor
histopathology

Lydia TamUSA

PAT-P-06

PATH-14

Genetic susceptibility and outcomes of pediatric, adolescent and young adult IDHmutant astrocytomas

Miriam Bornhorst

USA

PAT-P-08

PATH-22Comparison of supervised classification methods for central nervous system tumors
based on DNA-methylation

Brent OrrUSA

PAT-P-09

PATH-13

PLEOMORPHIC xanthoastrocytoma integrated genomic characterization - what have
we learned?

Caterina Giannini

USA

PAT-P-10

PATH-24

Molecular classification of high risk infant embryonal brain tumors enrolled in theACNS0334 trial: a report from the Children’s Oncology GroupBryan K. LiCanada

PAT-P-11

PATH-27

Mutation detection using plasma cell-free DNA in children with central nervous system
tumorsRoss Mangum

USA

PAT-P-12

PATH-15

Proteomic signatures predict grade in pediatric and young adult infiltrative astrocytomas Richard GrahamUSAPAT-P-13

PATH-19

Molecular classification based on the DNA methylation profile of central nervous system
Evelina Miele(CNS) tumors in children: two-years experience at the Bambino Gesù Hospital

Italy

PAT-P-14

PATH-29High frequency of clinically-relevant tumor variants detected by molecular testing ofFrank Y. Lin
high-risk pediatric CNS tumors – preliminary findings from the Texas KidsCanSeq study

USA

PAT-P-15

PATH-21

Telomere length analysis of CNS tumors in the Pediatric Brain Tumor Atlas

Kristina ColeUSA

PAT-P-16

PATH-07

Quality assurance in cerebrospinal fluid cytology assessment for medulloblastoma
staging leads to potential improved risk-group assessment in the prospective
multicenter HIT-2000 trial

Christian Hagel

Germany

PAT-P-17

PATH-20

Methylation array profiling of pediatric brain tumors; single centre experience

Michal Zapotocky

Czech Republic

PAT-P-18

PATH-23

Adult spinal cord astroblastoma with EWSR1-BEND2 fusion

Takeyoshi Tsutsui

Japan

PAT-P-19

PATH-26

RNA sequencing of formalin-fixed paraffin-embedded specimens in diagnostic routine
identifies clinically relevant gene fusions

Damian Stichel

Germany

PAT-P-20

PATH-28

Molecular diagnosis for central diagnosis of brain tumors from 2016 to 2019— A report
Yoshiko Nakano
from the Japan Children’s Cancer Group (JCCG)

Japan

PAT-P-21

PATH-30

Exosomes as a source of plasma ctDNA to identify point mutations in pediatric glioma
patients

Liana NobreBrazil

PAT-P-22

PATH-16

Correlation of pathological and radiographical diagnoses for children with brain tumors
at two major hospital in Kenya

Minda Okemwa

Kenya

PAT-P-23

PATH-31

The impact of molecular profiling of pediatric CNS tumors on tumor diagnosis andmanagement - a single center experience

Kazuhiro Sabet

USA

PAT-P-24

PATH-08

The importance of re-diagnosis of tumors previously classified as central nervous
system primitive neuroectodermal tumors

Naohide Fujita

Japan

PAT-P-25

PATH-09

SJMB12 clinical trial: discrepancy between local and central pathology in assessing
anaplastic medulloblastoma – report from a single site experienceDong-Anh Khuong-Quang

Australia

PAT-P-26

PATH-10

Prognostic relevant immunophenotypes of pediatric high-grade non-brainstem gliomas

Taisiya Mikhaleuskaya

Belarus

PAT-P-27

PATH-25

Genome-wide methylation analysis can segregate radiation-induced glioblastoma fromlate recurrence of medulloblatomas

Takamasa Hiraki

Japan

PAT-P-28

PATH-03

High-grade neuroepithelial tumor showing BCOR immunopositivity without exon 15
internal tandem duplications in a five-year-old boy: A case report

Shogo Wakita

Japan

PAT-P-29

PATH-05

A case of pilocytic astrocytoma harboring the FGFR1 gene mutation with a predominantNobuyoshi Sasaki
oligodendroglioma-like component.

PAT-P-30

PATH-18

High-grade neuroepithelial tumor (HGNET) in a pediatric case-series

Felipe SandersJapanBrazil